Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of OAS1 mRNA | increases expression | 19152381
|
D001564 |
Benzo(a)pyrene |
chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of OAS1 mRNA] | decreases reaction|increases expression | 19152381
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of OAS1 mRNA | decreases expression | 15336504
|
C007020 |
chlorophyllin |
chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of OAS1 mRNA] | decreases reaction|increases expression | 19152381
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of OAS1 mRNA | decreases expression | 19638242
|
C010452 |
estradiol-17 beta-benzoate |
estradiol-17 beta-benzoate results in decreased expression of OAS1 mRNA | decreases expression | 15972882
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of OAS1 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of OAS1 mRNA | increases expression | 19619570
|
C015854 |
estradiol valerate |
estradiol valerate results in decreased expression of OAS1 mRNA | decreases expression | 15972882
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of OAS1 mRNA | increases expression | 17616710
|
D010126 |
Ozone |
Ozone results in decreased expression of OAS1 mRNA | decreases expression | 16716893
|
D011070 |
Poly I-C |
Poly I-C results in increased expression of OAS1 mRNA | increases expression | 17669408
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of OAS1 mRNA | increases expression | 19155303
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of OAS1 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of OAS1 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of OAS1 mRNA | increases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of OAS1 mRNA | increases expression | 16054129 16647867
|
D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in increased expression of OAS1 mRNA | affects cotreatment|increases expression | 20370541
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.64 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 11752688 14514962 15322242 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.90 | 9612607 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.32 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.32 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.73 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.73 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.33 | 16434500 17620307 18056438 19052882 17162532 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.33 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.45 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.11 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.71 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.71 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
5.00 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.00 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.12 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.12 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.98 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.98 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.98 | 17289903 14630087 17261762 18497071 12948864 16675129 19861407 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.98 | 16818667 19011961 20859285 19189210 17440819 19084267 19288272 19059307 19066611 18855134 16873071 19115204 17049068 17893378 21138602 19103187 19289846 16202921 20544844 19189212 15668708 18815881 19200415 18351453 20005174 19221464 20065188 18629630 18984771 19155303 21152245 19244106 17261762 11161223 15565566 19142967 17242785 16273361 18821012 20135344 18997820 18425577 20390343 19487384 19410462 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.98 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.98 | 16166294 16873071 16443354 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.72 | 16777450 14754758 18417511 18315731 15516495 17626835 19059883 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.82 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.55 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.58 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.64 | 17162532 19208518 19539802 20727157 18494052 16935385 19394651 20214788 17428255 18056438 11831363 20514400 3581430 18665156 16698587 3084413 20084675 19919837 21159647 18788625 19701751 10672840 16779866 16288022 19335982 17173139 18393292 16569478 20007298 19052882 16830150 18691550 18785209 16681979 20524982 20512989 19822196 18210153 19519916 16878318 19107877 17055752 20101231 17978847 20935162 16328049 16540662 18506893 20432363 16502159 19383236 17761372 18978308 19418558 16807293 19171122 17138121 10737359 18971187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.64 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.64 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.64 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.62 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.62 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.66 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.12 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.82 | 21159647 2727394 17174075 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.82 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.49 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.49 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.83 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.83 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.46 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.46 | 16925845 8800419 14991402 9211117 9664655 9142499 9125849 9224671 10589399 17551590 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.43 | 19031437 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
marker/mechanism |
|
| |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.26 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.26 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.00 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.00 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.78 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.78 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.37 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
8.37 | 15040536 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.27 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.27 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
3.60 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.63 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
12.63 | 19155303 17893378 16202921 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.63 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 10568697 9294722 |
MESH:D007172 |
Erectile Dysfunction |
|
estradiol valerate |
5.88 | 14972507 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.21 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.65 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
4.65 | 15623463 16704527 15150132 15878914 15547721 16510608 15547733 15264214 16805852 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.97 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.97 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
13.57 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
13.57 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
13.57 | 18299183 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.27 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.26 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.86 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.86 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.04 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.22 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.25 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.25 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.25 | 9664655 14991402 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.77 | 12579204 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.13 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
3.52 | 20032539 11141242 11698656 17358032 11363243 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.85 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.25 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.92 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.43 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.43 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.43 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.00 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.12 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.12 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.61 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.79 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.79 | 18625569 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
12.79 | 12579204 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.79 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.47 | 20370541 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.75 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.19 | 19225113 15748426 16140955 17339181 12679006 17368321 17294898 17107899 19029980 16891316 17506722 16788101 17301526 16331271 16823087 19075265 17361223 17649720 16935935 17712046 17217047 16766008 19642359 19035177 9834237 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.19 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.85 | 18522880 19638242 20032147 18407596 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.83 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Poly I-C |
6.83 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.83 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.83 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.83 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.11 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.84 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.84 | 20434301 19073162 2422723 20405173 15885732 19996281 18644402 9163691 19294768 19427195 20137499 19256749 12771043 20492335 19850985 19642983 18977376 19690152 12112319 19255062 20452335 21167192 19638242 20583210 18754104 2862719 20101389 18978307 19090486 20501860 19812893 10737359 21278145 16942905 18648771 21047994 19551842 21071580 19499222 19426721 15175105 20118626 19254457 19833225 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.84 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.84 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
5.87 | 18093689 19009564 18164116 16267830 3124819 17854601 9362446 19004024 19519916 18079962 18282651 18544905 17942915 19539802 19126423 18775883 17174075 2563599 21159647 16842330 18308698 18253720 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.87 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.41 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.92 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.65 | 20464547 6695378 18520028 18816296 17053015 20869020 20135361 20064080 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.65 | 20970405 21163286 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
8.65 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
8.65 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.65 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
8.65 | 18800350 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.84 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.08 | 16891317 11807958 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.08 | 19196723 11731420 16827153 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.98 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.98 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.31 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.31 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.26 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.20 | 10496685 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.93 | 17358032 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.23 | 16381670 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.11 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.32 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.80 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.80 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.53 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.07 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.07 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.10 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.81 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
16.72 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.72 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
16.72 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.09 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.39 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.21 | 20387270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.86 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.86 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.31 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.31 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.20 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.48 | 18381685 18929643 18007984 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.60 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11222880 11118676 11896295 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.94 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.49 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.49 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.49 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.66 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.16 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.75 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.75 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.75 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.75 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.39 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.12 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
6.47 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
6.47 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
6.47 | 17575124 12958204 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
6.47 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
6.47 | 17696246 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.31 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.31 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.78 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.84 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.06 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.06 | 16712894 17572228 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.73 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.71 | 16752155 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.83 | 12579204 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.12 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |